Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Franchini

Showing results (211-220 of 749) with videos related to

Pageof 75
Sort By:
Clinical Chemistry and Laboratory Medicine|May 8, 2013
ABO blood group: old dogma, new perspectivesMassimo Franchini, Giancarlo Maria Liumbruno
Expert Opinion on Emerging Drugs|August 8, 2014
Emerging drugs for hemophilia BPier Mannuccio Mannucci, Massimo Franchini
Orphanet Journal of Rare Diseases|May 4, 2012
Past, present and future of hemophilia: a narrative reviewMassimo Franchini, Pier Mannuccio Mannucci
Blood Transfusion = Trasfusione Del Sangue|October 15, 2013
Beyond immunohaematology: the role of the ABO blood group in human diseasesGiancarlo Maria Liumbruno, Massimo Franchini
Seminars in Thrombosis and Hemostasis|December 24, 2016
Response to "Innovation in Hemophilia Therapies-'And Miles to Go, before [We] Sleep'"Pier Mannuccio Mannucci, Massimo Franchini
Haematologica|May 3, 2008
Interactions between genotype and phenotype in bleeding and thrombosisMassimo Franchini, Pier Mannuccio Mannucci
Annals of Medicine|March 14, 2015
Low-molecular-weight heparins and cancer: focus on antitumoral effectMassimo Franchini, Pier Mannuccio Mannucci
Analytical and Bioanalytical Chemistry|March 23, 2011
Letter to the editor regarding "Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing"Giuseppe Banfi, Massimo Franchini, Giuseppe Lippi
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 25, 2011
Screening and therapeutic management of lipoprotein(a) excess: review of the epidemiological evidence, guidelines and recommendationsGiuseppe Lippi, Massimo Franchini, Giovanni Targher
The New England Journal of Medicine|February 11, 2011
Safety of recombinant activated factor VII in randomized clinical trialsMassimo Franchini, Giovanni Targher, Giuseppe Lippi
Pageof 75

Showing results (211-220 of 749) with videos related to

Sort By:
Pageof 75
Clinical Chemistry and Laboratory Medicine|May 8, 2013
ABO blood group: old dogma, new perspectivesMassimo Franchini, Giancarlo Maria Liumbruno
Expert Opinion on Emerging Drugs|August 8, 2014
Emerging drugs for hemophilia BPier Mannuccio Mannucci, Massimo Franchini
Orphanet Journal of Rare Diseases|May 4, 2012
Past, present and future of hemophilia: a narrative reviewMassimo Franchini, Pier Mannuccio Mannucci
Blood Transfusion = Trasfusione Del Sangue|October 15, 2013
Beyond immunohaematology: the role of the ABO blood group in human diseasesGiancarlo Maria Liumbruno, Massimo Franchini
Seminars in Thrombosis and Hemostasis|December 24, 2016
Response to "Innovation in Hemophilia Therapies-'And Miles to Go, before [We] Sleep'"Pier Mannuccio Mannucci, Massimo Franchini
Haematologica|May 3, 2008
Interactions between genotype and phenotype in bleeding and thrombosisMassimo Franchini, Pier Mannuccio Mannucci
Annals of Medicine|March 14, 2015
Low-molecular-weight heparins and cancer: focus on antitumoral effectMassimo Franchini, Pier Mannuccio Mannucci
Analytical and Bioanalytical Chemistry|March 23, 2011
Letter to the editor regarding "Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing"Giuseppe Banfi, Massimo Franchini, Giuseppe Lippi
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 25, 2011
Screening and therapeutic management of lipoprotein(a) excess: review of the epidemiological evidence, guidelines and recommendationsGiuseppe Lippi, Massimo Franchini, Giovanni Targher
The New England Journal of Medicine|February 11, 2011
Safety of recombinant activated factor VII in randomized clinical trialsMassimo Franchini, Giovanni Targher, Giuseppe Lippi
Pageof 75